Cell and Tissue Banking

, Volume 6, Issue 4, pp 263–270 | Cite as

Should Deceased Donors be Tested for vCJD?



The 1997 Bovine Spongiform Encephalopathy enquiry and the 2001 Hepatitis C litigation judgement set the UK scene for evoking the precautionary principle and the legal precedent that liability for defective transfusion products should not be dependent on medical negligence, but on the mere fact of defectiveness. Animal models indicate that vCJD in humans, with infection via the oral route, is likely to be associated with infectivity within the lymphoreticular system (LRS). This is likely to appear prior to the involvement of the central nervous system and thus infectivity is likely to be present in the LRS before the onset of clinical disease. A number of relevant epidemiological studies using LRS tissue have shown a low, but measurable, existence of the carrier state in vCJD. Two possible cases of transmission of the abnormal prion of vCJD by blood transfusion suggested that tissues might also transmit and that testing of LRS tissue from deceased potential tissue donors should be considered as a first measure towards the prevention of vCJD transmission by tissues designated for use in transplantation. A variety of different tissues could be used as representative of the LRS, but each is associated with problems of feasibility and practicality. Assays for vCJD have not been validated in the context of donor screening rather than epidemiological studies nor on deceased donors. However, given the number of vCJD cases in the UK, significant attention should be paid to the logistical, ethical, social and other issues associated with undertaking vCJD testing of tissue donors, with a view to introducing testing of deceased tissue donors for vCJD disease or latency.


Analyte Assays Deceased tissue donor PrPsc (Prion Protein Scrapie) Tonsil TSE (Transmissible Spongiform Encephalophy) Variant Creutzfeldt Jacob Disease (vCJD) 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. A v National Blood Authority 2001. TNLR No 200 (QB Div) (QL) (Burton J). Google Scholar
  2. BSE Inquiry Report 2000. www.bseinquiry.gov.uk.Google Scholar
  3. Bruce, M.E., McConnell, I., Will, R.G., Ironside, J.W. 2001Detection of variant Creutzfeldt Jacob disease infectivity in extraneural tissuesLancet358208209CrossRefPubMedGoogle Scholar
  4. Centres for Disease Control1987aRapidly progressive dementia in a patient who received a cadaveric dura mater graftMMWR364955Google Scholar
  5. Centres for Disease Control1987bUpdate: Creutzfeldt-Jakob disease in a patient receiving a cadaveric dura mater graftMMWR36324325Google Scholar
  6. Centres for Disease Control1989Update: Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graftMMWR383743Google Scholar
  7. Centres for Disease Control1993Creutzfeldt-Jakob disease in patients who received a cadaveric dura mater graftMMWR42560563Spain 1985–1992Google Scholar
  8. Clarke P. and Ghani A.C. 2005. Projections of the future course of the primary vCJD epidemic in the UK: Inclusion of subclinical infection and the possibility of wider genetic susceptibility. J. Roy. Soc. Interface doi:10.1098/rsif.2004.0017 (published on line).Google Scholar
  9. Clinical Incidents Panel 2001. The management of possible exposure to CJD through medical procedures: A Consultation Paper.pp 14.2www.dh.gov.uk/assetRoot/04/07/82/21/04078221.pdf.Google Scholar
  10. Council of Europe 2002. Guide to Safety and Quality Assurance for Organs, Tissues and Cells.Google Scholar
  11. Department of Health. Quarterly analysis of the incidence of vCJDwebsite www.dh.gov.uk.Google Scholar
  12. Duffy, P., Wolf, J., Collins, G., Devoe, A.G., Steeten, B., Cowen, D. 1974Possible person to person transmission of Creutzfeldt-Jakob diseaseNew Engl. J. Med.290692693(Letter)PubMedGoogle Scholar
  13. `Guidelines for tissue bankingȁ9 in UK Blood Transfusion and Tissue Transplantation Guidelines.2002. Sixth Edition. The Stationary OfficeLondon.Available at http://www.transfusionguidelines.org.uk.Google Scholar
  14. Hill, A.F., Butterworth, R.J., Joiner, S., Jackson, G., Rossor, M.N., Thomas, D.J., Frosh, A., Tolley, N., Bell, J.E., Spencer, M., King, A., Al-Sharraj, S., Ironside, J.W., Lantos, P.L., Collinge, J. 1999Investigation of variant Creutzfeldt-Jacob disease and other human prion diseases with tonsil biopsy samplesLancet353183189CrossRefPubMedGoogle Scholar
  15. Hilton, D.A., Fathers, E., Edwards, P., Ironside, J.W., Zajick, J. 1998Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jacob diseaseLancet352703704CrossRefPubMedGoogle Scholar
  16. Hilton, D.A., Ghani, A.L., Conyers, L., Edwards, P., McCardle, L., Ritchie, D., Penney, M., Hegazy, D., Ironside, J.W. 2004Prevalence of lymphoreticular prion protein accumulation in UK tissue samplesJ. Pathol.203733739CrossRefPubMedGoogle Scholar
  17. Ironside, J.W., Hilton, D.A., Ghani, A., Johnston, N.J., Conyers, L., McCardle, L.M., Best, D. 2000Retrospective study of prion-protein accumulation in tonsil and appendix tissuesLancet35516931694CrossRefPubMedGoogle Scholar
  18. Lindgren, P.G., Hagberg, H., Eriksson, B., Glimelius, B., Magnusson, A., Sundstrom, C. 1985Excision biopsy of the spleen by ultrasonic guidanceBrit. J. Radiol.58853857PubMedCrossRefGoogle Scholar
  19. Llewelyn, C.A., Hewitt, P.E., Knight, R.S., Amar, K., Clousens, S., Mackenzie, J., Will, R.G. 2004Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusionLancet363417421CrossRefPubMedGoogle Scholar
  20. Manuelidis, E.E., Angelo, J.N., Gorgacz, E.J., Kim, J.H., Manuelidis, L. 1977Experimental Creutzfeldt-Jakob disease transmitted via the eye with infected corneaNew Engl. J. Med.29613341336PubMedCrossRefGoogle Scholar
  21. Microbiological Safety of Blood Tissues for Transplantation, Department of Health: Guidance on the microbiological safety of human tissues and organs used in transplantation (NHS ExecutiveAugust 2000).Google Scholar
  22. Muraca, S., Chait, P., Connolly, B.L., Baskin, K.M., Temple, M.J. 2001US-guided Core Biopsy of the Spleen in ChildrenRadiology218200206PubMedGoogle Scholar
  23. Peden, A.H., Head, M.W., Ritchie, D.L., Bell, J.E., Ironside, J.W. 2004Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patientLancet364527529CrossRefPubMedGoogle Scholar
  24. Sundar, S., Jha, T.K., Thakur, C.P., Engel, J., Sindermann, H., Fischer, C., Junge, K., Bryceson, A., Berman, J. 2002Oral Miltefosine for Indian Visceral LeishmaniasisNew Engl. J. Med.34717391746CrossRefPubMedGoogle Scholar
  25. Tabrizi, S.J., Elliott, C.L., Weismann, C. 2003Ethical issues in human prion diseasesBrit. Med. Bull.66305316PubMedGoogle Scholar
  26. Tange, R.A., Troost, D., Limburg, M. 1990Progressive fatal dementia (Creutzfeldt-Jakob disease) in a patient who received homograft tissue for tympanic membrane closureEur. Arch. Otorhinolaryngol.247199201CrossRefPubMedGoogle Scholar
  27. Thadani, V., Penar, P.L., Partington, J., Kalb, R., Janssen, R., Schonberger, L.B., Rabkin, C.S., Prichard, J.W. 1988Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graftJ. Neurosurg.69766769PubMedGoogle Scholar
  28. UK Blood Transfusion Tissue Transplantation Guidelines - vCJD Position Statement) http://www.transfusionguidelines.org.uk/docs/pdfs/position_statement_01_2005_02.pdf. Google Scholar
  29. Wadsworth, J.D.F., Joiner, S., Hill, A.F., Campbell, T.A., Desbruslais, M., Luthert, P.J., Collinge, J. 2001Tissue distribution of protease resistant prion protein in variant Creutzfeldt Jakob disease using a highly sensitive immunoblotting assayLancet358171180CrossRefPubMedGoogle Scholar
  30. Warwick R. and Kearney J. 2004. Should tonsil be used as an analyte from cadaveric tissue donors to test for variant CJD? abstract, European Association for Tissue Banking EATB Prague.Google Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.Tissue ServicesEdgwareUK
  2. 2.National Transfusion Microbiology LaboratoriesNational Blood ServiceEdgwareUK

Personalised recommendations